In vivo evaluation of different alterations of redox status by studying pharmacokinetics of nitroxides using magnetic resonance techniques

Redox Biology

Volumn 8, Issue , 2016, Pages 226-242

  Bačić, Goran ^a   Pavićević, Aleksandra ^a   Peyrot, Fabienne ^b,c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Electron paramagnetic resonance (EPR); Magnetic resonance imaging (MRI); Nitroxides; Pharmacokinetics; Reactive oxygen species (ROS); Redox state

Indexed keywords

ANTIOXIDANT; NITROXIDE DERIVATIVE; REACTIVE OXYGEN METABOLITE; FREE RADICAL; NITROGEN OXIDE; NITROXYL;

ARTICLE; BIOCHEMISTRY; BRAIN DISEASE; DIABETES MELLITUS; DRUG CLEARANCE; DRUG HALF LIFE; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; ELECTROMAGNETIC RADIATION; ELECTRON SPIN RESONANCE; EXPERIMENTAL ANIMAL; HUMAN; IN VIVO STUDY; MAGNETIC FIELD; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHARMACOKINETICS; PRIORITY JOURNAL; SKIN STRUCTURE; ANIMAL; BRAIN; ISOLATION AND PURIFICATION; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; PATHOLOGY;

ANIMALS; BRAIN; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICALS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; NITROGEN OXIDES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84955614455     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.10.007     Document Type: Article

References (153)

1. Martinovich G.G., Martinovich I.V., Cherenkevich S.N., Sauer H. Redox buffer capacity of the cell: theoretical and experimental approach. Cell. Biochem. Biophys. 2010, 58:75-83. 10.1007/s12013-010-9090-3.
2. Ma Q. Transcriptional responses to oxidative stress: Pathological and toxicological implications. Pharmacol. Ther. 2010, 125:376-393. 10.1016/j.pharmthera.2009.11.004.
3. Bartosz G. Use of spectroscopic probes for detection of reactive oxygen species. Clin. Chim. Acta 2006, 368:53-76. 10.1016/j.cca.2005.12.039.
4. Zavoisky E. Spin magnetic resonance in the decimeter-wave region. J. Phys. USSR 1946, 10:197-198.
5. Froncisz W., Hyde J.S. The loop-gap resonator: a new microwave lumped circuit ESR sample structure. J. Magn. Reson. 1982, 47:515-521. 10.1016/0022-2364(82)90221-9.
6. Sotgiu A. Resonator design for in vivo ESR spectroscopy. J. Magn. Reson. 1985, 65:206-214. 10.1016/0022-2364(85)90002-2.
7. Berliner L.J., Fujii H. Magnetic resonance imaging of biological specimens by electron paramagnetic resonance of nitroxide spin labels. Science 1985, 227:517-519. 10.1126/science.2981437.
8. Berliner L.J., Fujii H., Wan X., Lukiewicz S.J. Feasibility study of imaging a living murine tumor by electron paramagnetic resonance. Magn. Reson. Med. 1987, 4:380-384. 10.1002/mrm.1910040410.
9. Maltempo M.M., Eaton S.S., Eaton G.R. Spectral-spatial two-dimensional EPR imaging. J. Magn. Reson. 1987, 72:449-455. 10.1016/0022-2364(87)90149-1.
10. Bačić G., Demsar F., Zolnai Z., Swartz H.M. Contrast enhancement in ESR imaging: role of oxygen. Magn. Reson. Med. Biol. 1988, 1:55-65.
11. Bačić G., Walczak T., Demsar F., Swartz H.M. Electron spin resonance imaging of tissues with lipid-rich areas. Magn. Reson. Med. 1988, 8:209-219. 10.1002/mrm.1910080211.
12. Woods R.K., Bačić G.G., Lauterbur P.C., Swartz H.M. Three-dimensional electron spin resonance imaging. J. Magn. Reson. 1989, 84:247-254. 10.1016/0022-2364(89)90368-5.
13. Dobrucki J.W., Demsar F., Walczak T., Woods R.K., Bacic G., Swartz H.M. Electron spin resonance microscopy of an in vitro tumor model. Br. J. Cancer 1990, 61:221-224. 10.1038/bjc.1990.41.
14. Bacic G., Nilges M.J., Magin R.L., Walczak T., Swartz H.M. In vivo localized ESR spectroscopy reflecting metabolism. Magn. Reson. Med. 1989, 10:266-272. 10.1002/mrm.1910100211.
15. Utsumi H., Muto E., Masuda S., Hamada A. In vivo ESR measurement of free radicals in whole mice. Biochem. Biophys. Res. Commun. 1990, 172:1342-1348. 10.1016/0006-291X(90)91597-L.
16. Ferrari M., Colacicchi S., Gualtieri G., Santini M.T., Sotgiu A. Whole mouse nitroxide free radical pharmacokinetics by low frequency electron paramagnetic resonance. Biochem. Biophys. Res. Commun. 1990, 166:168-173. 10.1016/0006-291X(90)91926-J.
17. Miura Y., Utsumi H., Hamada A. Effects of inspired oxygen concentration on in vivo redox reaction of nitroxide radicals in whole mice. Biochem. Biophys. Res. Commun. 1992, 182:1108-1114. 10.1016/0006-291X(92)91846-I.
18. Takeshita K., Utsumi H., Hamada A. ESR measurement of radical clearance in lung of whole mouse. Biochem. Biophys. Res. Commun. 1991, 177:874-880. 10.1016/0006-291X(91)91871-9.
19. Ishida S., Matsumoto S., Yokoyama H., Mori N., Kumashiro H., Tsuchihashi N., Ogata T., Yamada M., Ono M., Kitajima T., Kamada H., Yoshida E. An ESR-CT imaging of the head of a living rat receiving an administration of a nitroxide radical. Magn. Reson. Imaging 1992, 10:109-114. 10.1016/0730-725X(92)90379-E.
20. Gomi F., Utsumi H., Hamada A., Matsuo M. Aging retards spin clearance from mouse brain and food restriction prevents its age-dependent retardation. Life Sci. 1993, 52:2027-2033. 10.1016/0024-3205(93)90687-X.
21. Alecci M., Ferrari M., Quaresima V., Sotgiu A., Ursini C.L. Simultaneous 280 MHz EPR imaging of rat organs during nitroxide free radical clearance. Biophys. J. 1994, 67:1274-1279. 10.1016/S0006-3495(94)80599-5.
22. Komarov A.M., Joseph J., Lai C.-S. In vivo pharmacokinetics of nitroxides in mice. Biochem. Biophys. Res. Commun. 1994, 201:1035-1042. 10.1006/bbrc.1994.1806.
23. In Vivo EPR (ESR): Theory and Application, Biological Magnetic Resonance 2003, Vol. 18. Kluwer Academic/Plenum, New York. 10.1007/978-1-4615-0061-2.
24. Swartz H.M., Sentjurc M., Morse P.D. Cellular metabolism of water-soluble nitroxides: effect on rate of reduction of cell/nitroxide ratio, oxygen concentrations and permeability of nitroxides. Biochim. Biophys. Acta 1986, 888:82-90. 10.1016/0167-4889(86)90073-X.
25. Swartz H.M. Use of nitroxides to measure redox metabolism in cells and tissues. J. Chem. Soc. Faraday Trans. 1: Phys. Chem. Condens. Ph. 1987, 83:191-202. 10.1039/F19878300191.
26. Brasch R.C. Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. Radiology 1983, 147:781-788. 10.1148/radiology.147.3.6342034.
27. Hyodo F., Chuang K.-H., Goloshevsky A.G., Sulima A., Griffiths G.L., Mitchell J.B., Koretsky A.P., Krishna M.C. Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J. Cereb. Blood Flow Metab. 2008, 28:1165-1174. 10.1038/jcbfm.2008.5.
28. Davis R.M., Matsumoto S., Bernardo M., Sowers A., Matsumoto K.-I., Krishna M.C., Mitchell J.B. Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape. Free Radic. Biol. Med. 2011, 50:459-468. 10.1016/j.freeradbiomed.2010.11.028.
29. Davis R.M., Sowers A.L., DeGraff W., Bernardo M., Thetford A., Krishna M.C., Mitchell J.B. A novel nitroxide is an effective brain redox imaging contrast agent and in vivo radioprotector. Free Radic. Biol. Med. 2011, 51:780-790. 10.1016/j.freeradbiomed.2011.05.019.
30. Caia G.L., Efimova O.V., Velayutham M., El-Mahdy M.A., Abdelghany T.M., Kesselring E., Petryakov S., Sun Z., Samouilov A., Zweier J.L. Organ specific mapping of in vivo redox state in control and cigarette smoke-exposed mice using EPR/NMR co-imaging. J. Magn. Reson. 2012, 216:21-27. 10.1016/j.jmr.2011.10.017.
31. Zhelev Z., Bakalova R., Aoki I., Lazarova D., Saga T. Imaging of superoxide generation in the dopaminergic area of the brain in Parkinson's disease, using mito-TEMPO. ACS Chem. Neurosci. 2013, 4:1439-1445. 10.1021/cn400159h.
32. Elas M., Ichikawa K., Halpern H.J. Oxidative stress imaging in live animals with techniques based on electron paramagnetic resonance. Radiat. Res. 2012, 177:514-523. 10.1667/RR2668.1.
33. Swartz H.M. The measurement of oxygen in vivo using EPR techniques. In vivo EPR (ESR): theory and application. Biological Magnetic Resonance 2003, Vol. 18:403-440. Kluwer Academic/Plenum, New York. 10.1007/978-1-4615-0061-2_15.
34. Ahmad R., Kuppusamy P. Theory, instrumentation, and applications of electron paramagnetic resonance oximetry. Chem. Rev. 2010, 110:3212-3236. 10.1021/cr900396q.
35. Subramanian S., Devasahayam N., McMillan A., Matsumoto S., Munasinghe J.P., Saito K., Mitchell J.B., Chandramouli G.V.R., Krishna M.C. Reporting of quantitative oxygen mapping in EPR imaging. J. Magn. Reson. 2012, 214:244-251. 10.1016/j.jmr.2011.11.013.
36. He G., Deng Y., Li H., Kuppusamy P., Zweier J.L. EPR/NMR co-imaging for anatomic registration of free-radical images. Magn. Reson. Med. 2002, 47:571-578. 10.1002/mrm.10077.
37. Hyodo F., Yasukawa K., Yamada K.-I., Utsumi H. Spatially resolved time-course studies of free radical reactions with an EPRI/MRI fusion technique. Magn. Reson. Med. 2006, 56:938-943. 10.1002/mrm.21019.
38. Fujii H., Aoki M., Haishi T., Itoh K., Sakata M. Development of an ESR/MR dual-imaging system as a tool to detect bioradicals. Magn. Reson. Med. Sci. 2006, 5:17-23. 10.2463/mrms.5.17.
39. Samouilov A., Caia G.L., Kesselring E., Petryakov S., Wasowicz T., Zweier J.L. Development of a hybrid EPR/NMR coimaging system. Magn. Reson. Med. 2007, 58:156-166. 10.1002/mrm.21205.
40. Lurie D.J., Bussell D.M., Bell L.H., Mallard J.R. Proton-electron double magnetic resonance imaging of free radical solutions. J. Magn. Reson. 1988, 76:366-370. 10.1016/0022-2364(88)90123-0.
41. Krishna M.C., English S., Yamada K., Yoo J., Murugesan R., Devasahayam N., Cook J.A., Golman K., Ardenkjaer-Larsen J.H., Subramanian S., Mitchell J.B. Overhauser enhanced magnetic resonance imaging for tumor oximetry: Coregistration of tumor anatomy and tissue oxygen concentration. Proc. Natl. Acad. Sci. USA 2002, 99:2216-2221. 10.1073/pnas.042671399.
42. Yamato M., Shiba T., Yamada K.-I., Watanabe T., Utsumi H. Noninvasive assessment of the brain redox status after transient middle cerebral artery occlusion using Overhauser-enhanced magnetic resonance imaging. J. Cereb. Blood Flow Metab. 2009, 29:1655-1664. 10.1038/jcbfm.2009.84.
43. Yamato M., Shiba T., Naganuma T., Ichikawa K., Utsumi H., Yamada K.-I. Overhauser-enhanced magnetic resonance imaging characterization of mitochondria functional changes in the 6-hydroxydopamine rat model. Neurochem. Int. 2011, 59:804-811. 10.1016/j.neuint.2011.08.010.
44. Lurie D.J., Foster M.A., Yeung D., Hutchison J.M.S. Design, construction and use of a large-sample field-cycled PEDRI imager. Phys. Med. Biol. 1998, 43:1877-1886. 10.1088/0031-9155/43/7/008.
45. Matsumoto K.-I., Subramanian S., Murugesan R., Mitchell J.B., Krishna M.C. Spatially resolved biologic information from in vivo EPRI, OMRI, and MRI. Antioxid. Redox Signal. 2007, 9:1125-1141. 10.1089/ars.2007.1638.
46. Hyodo F., Murugesan R., Matsumoto K.-I., Hyodo E., Subramanian S., Mitchell J.B., Krishna M.C. Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI. J. Magn. Reson. 2008, 190:105-112. 10.1016/j.jmr.2007.10.013.
47. Colacicchi S., Ferrari M., Sotgiu A. In vivo electron paramagnetic resonance spectroscopy/imaging: first experiences, problems, and perspectives. Int. J. Biochem. 1992, 24:205-214. 10.1016/0020-711X(92)90248-Y.
48. 4-. Free Radic. Biol. Med. 1999, 27:329-333. 10.1016/S0891-5849(99)00049-0.
49. Khan N., Swartz H. Measurements in vivo of parameters pertinent to ROS/RNS using EPR spectroscopy. Mol. Cell. Biochem. 2002, 234/235:341-357. 10.1023/A:1015938528432.
50. Hyodo F., Matsumoto S., Devasahayam N., Dharmaraj C., Subramanian S., Mitchell J.B., Krishna M.C. Pulsed EPR imaging of nitroxides in mice. J. Magn. Reson. 2009, 197:181-185. 10.1016/j.jmr.2008.12.018.
51. Fujii H., Sato-Akaba H., Kawanishi K., Hirata H. Mapping of redox status in a brain-disease mouse model by three-dimensional EPR imaging. Magn. Reson. Med. 2011, 65:295-303. 10.1002/mrm.22598.
52. Roshchupkina G.I., Bobko A.A., Bratasz A., Reznikov V.A., Kuppusamy P., Khramtsov V.V. In vivo EPR measurement of glutathione in tumor-bearing mice using improved disulfide biradical probe. Free Radic. Biol. Med. 2008, 45:312-320. 10.1016/j.freeradbiomed.2008.04.019.
53. He G., Kutala V.K., Kuppusamy P., Zweier J.L. In vivo measurement and mapping of skin redox stress induced by ultraviolet light exposure. Free Radic. Biol. Med. 2004, 36:665-672. 10.1016/j.freeradbiomed.2003.11.024.
54. Yordanov A.T., Yamada K.-I., Krishna M.C., Russo A., Yoo J., English S., Mitchell J.B., Brechbiel M.W. Acyl-protected hydroxylamines as spin label generators for EPR brain imaging. J. Med. Chem. 2002, 45:2283-2288. 10.1021/jm0105169.
55. Giotta G.J., Wang H.H. Reduction of nitroxide free radicals by biological materials. Biochem. Biophys. Res. Commun. 1972, 46:1576-1580. 10.1016/0006-291X(72)90788-7.
56. 15N-perdeuterated Tempone. Biochim. Biophys. Acta 1989, 992:131-133. 10.1016/0304-4165(89)90060-3.
57. Swartz H.M. Principles of the metabolism of nitroxides and their implications for spin trapping. Free Radic. Res. Commun. 1990, 9:399-405. 10.3109/10715769009145700.
58. Couet W.R., Brasch R.C., Sosnovsky G., Lukszo J., Prakash I., Gnewech C.T., Tozer T.N. Influence of chemical structure of nitroxyl spin labels on their reduction by ascorbic acid. Tetrahedron 1985, 41:1165-1172. 10.1016/S0040-4020(01)96516-0.
59. Keana J.F.W., Pou S., Rosen G.M. Nitroxides as potential contrast enhancing agents for MRI application: influence of structure on the rate of reduction by rat hepatocytes, whole liver homogenate, subcellular fractions, and ascorbate. Magn. Reson. Med. 1987, 5:525-536. 10.1002/mrm.1910050603.
60. Morris S., Sosnovsky G., Hui B., Huber C.O., Rao N.U.M., Swartz H.M. Chemical and electrochemical reduction rates of cyclic nitroxides (nitroxyls). J. Pharm. Sci. 1991, 80:149-152. 10.1002/jps.2600800212.
61. Iannone A., Hu H., Tomasi A., Vannini V., Swartz H.M. Metabolism of aqueous soluble nitroxides in hepatocytes: effects of cell integrity, oxygen, and structure of nitroxides. Biochim. Biophys. Acta 1989, 991:90-96. 10.1016/0304-4165(89)90033-0.
62. Chen K., Glockner J.F., Morse P.D., Swartz H.M. Effects of oxygen on the metabolism of nitroxide spin labels in cells. Biochemistry 1989, 28:2496-2501. 10.1021/bi00432a022.
63. Ueda A., Nagase S., Yokoyama H., Tada M., Noda H., Ohya H., Kamada H., Hirayama A., Koyama A. Importance of renal mitochondria in the reduction of TEMPOL, a nitroxide radical. Mol. Cell. Biochem. 2003, 244:119-124. 10.1023/A:1022477530291.
64. Iannone A., Tomasi A., Vannini V., Swartz H.M. Metabolism of nitroxide spin labels in subcellular fraction of rat liver: I. Reduction by microsomes. Biochim. Biophys. Acta 1990, 1034:285-289. 10.1016/0304-4165(90)90052-X.
65. Samuni Y., Gamson J., Samuni A., Yamada K., Russo A., Krishna M.C., Mitchell J.B. Factors influencing nitroxide reduction and cytotoxicity in vitro. Antioxid. Redox Signal. 2004, 6:587-595. 10.1089/152308604773934341.
66. Iannone A., Tomasi A., Vannini V., Swartz H.M. Metabolism of nitroxide spin labels in subcellular fractions of rat-liver. II. Reduction in the cytosol. Biochim. Biophys. Acta 1990, 1034:290-293. 10.1016/0304-4165(90)90053-Y.
67. Chen K.-Y., McLaughlin M.G. Differences in the reduction kinetics of incorporated spin labels in undifferentiated and differentiated mouse neuroblastoma cells. Biochim. Biophys. Acta 1985, 845:189-195. 10.1016/0167-4889(85)90176-4.
68. Suzuki-Nishimura T., Swartz H.M. Reduction of lipid-soluble nitroxides in CHO cells and macrophage tumor cells. Free Radic. Biol. Med. 1994, 17:473-479. 10.1016/0891-5849(94)90174-0.
69. Suzuki-Nishimura T., Swartz H.M. Characterization of redox activity in resting and activated mast cells by reduction and reoxidation of lipophilic nitroxides. Gen. Pharmacol. 1998, 31:617-623. 10.1016/S0306-3623(98)00066-4.
70. Chen K., Swartz H.M. Oxidation of hydroxylamines to nitroxide spin labels in living cells. Biochim. Biophys. Acta 1988, 970:270-277. 10.1016/0167-4889(88)90126-7.
71. Yamaguchi T., Nakano T., Kimoto E. Oxidation of nitroxide radicals by the reaction of hemoglobin with hydrogen peroxide. Biochem. Biophys. Res. Commun. 1984, 120:534-539. 10.1016/0006-291X(84)91287-7.
72. Krishna M.C., Samuni A., Taira J., Goldstein S., Mitchell J.B., Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins - kinetics and mechanism. J. Biol. Chem. 1996, 271:26018-26025. 10.1074/jbc.271.42.26018.
73. Krishna M.C., Grahame D.A., Samuni A., Mitchell J.B., Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc. Natl. Acad. Sci. USA 1992, 89:5537-5541. 10.1073/pnas.89.12.5537.
74. Goldstein S., Merenyi G., Russo A., Samuni A. The role of oxoammonium cation in the SOD-mimic activity of cyclic nitroxides. J. Am. Chem. Soc. 2003, 125:789-795. 10.1021/ja028190w.
75. Goldstein S., Samuni A., Hideg K., Merenyi G. Structure-activity relationship of cyclic nitroxides as SOD mimics and scavengers of nitrogen dioxide and carbonate radicals. J. Phys. Chem. A 2006, 110:3679-3685. 10.1021/jp056869r.
76. Goldstein S., Samuni A., Russo A. Reaction of cyclic nitroxides with nitrogen dioxide: the intermediacy of the oxoammonium cations. J. Am. Chem. Soc. 2003, 125:8364-8370. 10.1021/ja035286x.
77. Goldstein S., Samuni A., Merenyi G. Reactions of nitric oxide, peroxynitrite, and carbonate radicals with nitroxides and their corresponding oxoammonium cations. Chem. Res. Toxicol. 2004, 17:250-257. 10.1021/tx0342363.
78. Samuni A., Goldstein S., Russo A., Mitchell J.B., Krishna M.C., Neta P. Kinetics and mechanism of hydroxyl radical and OH-adduct radical reactions with nitroxides and with their hydroxylamines. J. Am. Chem. Soc. 2002, 124:8719-8724. 10.1021/ja017587h.
79. Lardinois O.M., Maltby D.A., Medzihradszky K.F., de Montellano P.R.O., Tomer K.B., Mason R.P., Deterding L.J. Spin scavenging analysis of myoglobin protein-centered radicals using stable nitroxide radicals: characterization of oxoammonium cation-induced modifications. Chem. Res. Toxicol. 2009, 22:1034-1049. 10.1021/tx9000094.
80. Goldstein S., Samuni A. Kinetics and mechanism of peroxyl radical reactions with nitroxides. J. Phys. Chem. A 2007, 111:1066-1072. 10.1021/jp0655975.
81. Israeli A., Patt M., Oron M., Samuni A., Kohen R., Goldstein S. Kinetics and mechanism of the comproportionation reaction between oxoammonium cation and hydroxylamine derived from cyclic nitroxides. Free Radic. Biol. Med. 2005, 38:317-324. 10.1016/j.freeradbiomed.2004.09.037.
82. Dragutan I., Mehlhorn R.J. Modulation of oxidative damage by nitroxide free radicals. Free Radic. Res. 2007, 41:303-315. 10.1080/10715760601089356.
83. Bar-On P., Mohsen M., Zhang R., Feigin E., Chevion M., Samuni A. Kinetics of nitroxide reaction with iron(II). J. Am. Chem. Soc. 1999, 121:8070-8073. 10.1021/ja990623g.
84. Zhang R., Goldstein S., Samuni A. Kinetics of superoxide-induced exchange among nitroxide antioxidants and their oxidized and reduced forms. Free Radic. Biol. Med. 1999, 26:1245-1252. 10.1016/S0891-5849(98)00328-1.
85. M. Mojović, A. Popović-Bijelić, A. Pavićević, S. Stamenković, M. Jovanović, P.R. Andjus, G. Bačić. Probing spin-probes. The EPR in vivo study of pharmacokinetics of two spin-probes, in: Proceedings of the 12th International Conference on Fundamental and Applied Aspects of Physical Chemistry, Belgrade, Serbia, 2014, pp. 550-553.
86. Nishino N., Yasui H., Sakurai H. In vivo L-band ESR and quantitative pharmacokinetic analysis of stable spin probes in rats and mice. Free. Radic. Res. 1999, 31:35-51. 10.1080/10715769900300581.
87. Sano T., Umeda F., Hashimoto T., Nawata H., Utsumi H. Oxidative stress measurement by in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia 1998, 41:1355-1360. 10.1007/s001250051076.
88. Quaresima V., Alecci M., Ferrari M., Sotgiu A. Whole rat electron paramagnetic resonance imaging of a nitroxide free radical by a radio frequency (280MHz) spectrometer. Biochem. Biophys. Res. Commun. 1992, 183:829-835. 10.1016/0006-291X(92)90558-3.
89. Sano H., Matsumoto K.-I., Utsumi H. Synthesis and imaging of blood-brain-barrier permeable nitroxyl-probes for free radical reactions in brain of living mice. Biochem. Mol. Biol. Int. 1997, 42:641-647. 10.1080/15216549700203051.
90. Sano H., Naruse M., Matsumoto K.-I., Oi T., Utsumi H. A new nitroxyl-probe with high retention in the brain and its application for brain imaging. Free Radic. Biol. Med. 2000, 28:959-969. 10.1016/S0891-5849(00)00184-2.
91. Utsumi H., Sano H., Naruse M., Matsumoto K.-I., Ichikawa K., Oi T. Nitroxyl probes for brain research and their application to brain imaging. Methods Enzym. 2002, 352:494-506. 10.1016/S0076-6879(02)52043-7.
92. Yokayama H., Itoh O., Aoyama M., Obara H., Ohya H., Kamada H. In vivo temporal EPR imaging of the brain of rats by using two types of blood-brain barrier-permeable nitroxide radicals. Magn. Reson. Imaging 2002, 20:277-284. 10.1016/S0730-725X(02)00491-5.
93. Gallez B., Bacic G., Goda F., Jiang J., O'Hara J.A., Dunn J.F., Swartz H.M. Use of nitroxides for assessing perfusion, oxygenation, and viability of tissues: in vivo EPR and MRI studies. Magn. Reson. Med. 1996, 35:97-106. 10.1002/mrm.1910350113.
94. Hahn S.M., Krishna M.C., DeLuca A.M., Coffin D., Mitchell J.B. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector. Free Radic. Biol. Med. 2000, 28:953-958. 10.1016/S0891-5849(00)00176-3.
95. Yamato M., Egashira T., Utsumi H. Application of in vivo ESR spectroscopy to measurement of cerebrovascular ROS generation in stroke. Free Radic. Biol. Med. 2003, 35:1619-1631. 10.1016/j.freeradbiomed.2003.09.013.
96. Zhelev Z., Matsumoto K.-I., Gadjeva V., Bakalova R., Aoki I., Zheleva A., Anzai K. EPR signal reduction kinetic of several nitroxyl derivatives in blood in vitro and in vivo. Gen. Physiol. Biophys. 2009, 28:356-362. 10.4149/gpb_2009_04_356.
97. Matsumoto K.-I., Krishna M.C., Mitchell J.B. Novel pharmacokinetic measurement using electron paramagnetic resonance spectroscopy and simulation of in vivo decay of various nitroxyl spin probes in mouse blood. J. Pharmacol. Exp. Ther. 2004, 310:1076-1083. 10.1124/jpet.104.066647.
98. Hyodo F., Matsumoto K.-I., Matsumoto A., Mitchell J.B., Krishna M.C. Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-selective contrast agent. Cancer Res. 2006, 66:9921-9928. 10.1158/0008-5472.CAN-06-0879.
99. Zhelev Z., Bakalova R., Aoki I., Matsumoto K.-I., Gadjeva V., Anzai K., Kanno I. Nitroxyl radicals for labeling of conventional therapeutics and noninvasive magnetic resonance imaging of their permeability for blood-brain barrier: relationship between structure, blood clearance, and MRI signal dynamics in the brain. Mol. Pharm. 2009, 6:504-512. 10.1021/mp800175k.
100. Halpern H.J., Peric M., Yu C., Barth E.D., Chandramouli G.V.R. In vivo spin-label murine pharmacodynamics using low-frequency electron paramagnetic resonance imaging. Biophys. J. 1996, 71:403-409. 10.1016/S0006-3495(96)79241-X.
101. Saito K., Takeshita K., Anzai K., Ozawa T. Pharmacokinetic study of acyl-protected hydroxylamine probe, 1-acetoxy-3-carbamoyl-2,2,5,5-tetramethylpyrrolidine, for in vivo measurements of reactive oxygen species. Free Radic. Biol. Med. 2004, 36:517-525. 10.1016/j.freeradbiomed.2003.11.010.
102. Mäder K., Bacic G., Swartz H.M. In vivo detection of anthralin-derived free radicals in the skin of hairless mice by low-frequency electron paramagnetic resonance spectroscopy. J. Investig. Dermatol. 1995, 104:514-517. 10.1111/1523-1747.ep12605998.
103. Vanea E., Charlier N., DeWever J., Dinguizli M., Feron O., Baurain J.-F., Gallez B. Molecular electron paramagnetic resonance imaging of melanin in melanomas: a proof-of-concept. NMR Biomed. 2008, 21:296-300. 10.1002/nbm.1241.
104. Khan N., Williams B.B., Swartz H.M. Clinical applications of in vivo EPR: rationale and initial results. Appl. Magn. Reson. 2006, 30:185-199. 10.1007/BF03166718.
105. Fuchs J., Groth N., Herrling T., Milbradt R., Zimmer G., Packer L. Electron paramagnetic resonance (EPR) imaging in skin: biophysical and biochemical microscopy. J. Investig. Dermatol. 1992, 98:713-719. 10.1111/1523-1747.ep12499919.
106. Fuchs J., Freisleben H.J., Podda M., Zimmer G., Milbradt R., Packer L. Nitroxide radical biostability in skin. Free. Radic. Biol. Med. 1993, 15:415-423. 10.1016/0891-5849(93)90041-R.
107. Fuchs J., Groth N., Herrling T. Cutaneous tolerance to nitroxide free radicals in human skin. Free Radic. Biol. Med. 1998, 24:643-648. 10.1016/S0891-5849(97)00322-5.
108. Gabrijelčič V., Šentjurc M., Schara M. The measurement of liposome entrapped molecules' penetration into the skin: a 1D-EPR and EPR kinetic imaging study. Int. J. Pharm. 1994, 102:151-158. 10.1016/0378-5173(94)90050-7.
109. Šentjurc M., Vrhovnik K., Kristl J. Liposomes as a topical delivery system: the role of size on transport studied by EPR imaging method. J. Control. Release 1999, 59:87-97. 10.1016/S0168-3659(98)00181-3.
110. Fuchs J., Groth N., Herrling T., Zimmer G. Electron paramagnetic resonance studies on nitroxide radical 2,2,5,5-tetramethyl-4-piperidin-1-oxyl (TEMPO) redox reactions in human skin. Free Radic. Biol. Med. 1997, 22:967-976. 10.1016/S0891-5849(96)00433-9.
111. Herrling T., Jung K., Fuchs J. Measurements of UV-generated free radicals/reactive oxygen species (ROS) in skin. Spectrochim. Acta Part A 2006, 63:840-845. 10.1016/j.saa.2005.10.013.
112. Takeshita K., Chi C., Hirata H., Ono M., Ozawa T. In vivo generation of free radicals in the skin of live mice under ultraviolet light, measured by L-band EPR spectroscopy. Free Radic. Biol. Med. 2006, 40:876-885. 10.1016/j.freeradbiomed.2005.10.049.
113. Herrling T., Fuchs J., Rehberg J., Groth N. UV-induced free radicals in the skin detected by ESR spectroscopy and imaging using nitroxides. Free. Radic. Biol. Med. 2003, 35:59-67. 10.1016/S0891-5849(03)00241-7.
114. Takeshita K., Takajo T., Hirata H., Ono M., Utsumi H. In vivo oxygen radical generation in the skin of the protoporphyria model mouse with visible light exposure: an L-band ESR study. J. Investig. Dermatol. 2004, 122:1463-1470. 10.1111/j.0022-202X.2004.22601.x.
115. He G., Samouilov A., Kuppusamy P., Zweier J.L. In vivo EPR imaging of the distribution and metabolism of nitroxide radicals in human skin. J. Magn. Reson. 2001, 148:155-164. 10.1006/jmre.2000.2226.
116. Jurkiewicz B.A., Buettner G.R. Ultraviolet light-induced free radical formation in skin: an electron paramagnetic resonance study. Photochem. Photobiol. 1994, 59:1-4. 10.1111/j.1751-1097.1994.tb04993.x.
117. Jurkiewicz B.A., Buettner G.R. EPR detection of free radicals in UV-irradiated skin: mouse versus human. Photochem. Photobiol. 1996, 64:918-922. 10.1111/j.1751-1097.1996.tb01856.x.
118. Yokoyama H., Morinobu S., Ueda Y. EPRI to estimate the in vivo intracerebral reducing ability in adolescent rats subjected to neonatal isolation. J. Magn. Reson. Imaging 2006, 23:637-640. 10.1002/jmri.20560.
119. Yokoyama H., Ueda Y., Itoh O., Ikeda T., Noor J.I., Ikenoue T. EPR imaging to estimate the in vivo intracerebral reducing ability of mature rats after neonatal hypoxic-ischemic brain injury. Magn. Reson. Imaging 2004, 22:1305-1309. 10.1016/j.mri.2004.09.003.
120. Yokoyama H., Lin Y., Itoh O., Ueda Y., Nakajima A., Ogata T., Sato T., Ohya-Nishiguchi H., Kamada H. EPR imaging for in vivo analysis of the half-life of a nitroxide radical in the hippocampus and cerebral cortex of rats after epileptic seizures. Free Radic. Biol. Med. 1999, 27:442-448. 10.1016/S0891-5849(99)00093-3.
121. Yokoyama H., Itoh O., Aoyama M., Obara H., Ohya H., Kamada H. In vivo EPR imaging by using an acyl-protected hydroxylamine to analyze intracerebral oxidative stress in rats after epileptic seizures. Magn. Reson. Imaging 2000, 18:875-879. 10.1016/S0730-725X(00)00183-1.
122. Fujii H.G., Sato-Akaba H., Emoto M.C., Itoh K., Ishihara Y., Hirata H. Noninvasive mapping of the redox status in septic mouse by in vivo electron paramagnetic resonance imaging. Magn. Reson. Imaging 2013, 31:130-138. 10.1016/j.mri.2012.06.021.
123. Yokayama H., Itoh O., Ohya-Nishiguchi H., Kamada H. Reducing ability of the striatum and cerebral cortex in rats following acute administration of risperidone or haloperidol: an estimation by in vivo electron paramagnetic resonance imaging. Neurochem. Res. 2002, 27:243-248. 10.1023/A:1014840722626.
124. Yokoyama H., Ishida S.-I., Ogata T. In vivo temporal EPR study using a region-selected intensity determination method to estimate cerebral reducing ability in rats treated with olanzapine. Magn. Reson. Imaging 2010, 28:898-902. 10.1016/j.mri.2010.03.019.
125. Kuppusamy P., Zweier J.L. Cardiac applications of EPR imaging. NMR Biomed. 2004, 17:226-239. 10.1002/nbm.912.
126. Leonard S.S., Mowrey K., Pack D., Shi X., Castranova V., Kuppusamy P., Vallyathan V. In vivo bioassays of acute asbestosis and its correlation with ESR spectroscopy and imaging in redox status. Mol. Cell. Biochem. 2002, 234/235:369-377. 10.1023/A:1015919101174.
127. Han J.-Y., Takeshita K., Utsumi H. Noninvasive detection of hydroxyl radical generation in lung by diesel exhaust particles. Free Radic. Biol. Med. 2001, 30:516-525. 10.1016/S0891-5849(00)00501-3.
128. Ahsan M.K., Nakamura H., Tanito M., Yamada K., Utsumi H., Yodoi J. Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt. Free Radic. Biol. Med. 2005, 39:1549-1559. 10.1016/j.freeradbiomed.2005.07.016.
129. Takeshita K., Hamada A., Utsumi H. Mechanisms related to reduction of radical in mouse lung using an L-band ESR spectrometer. Free Radic. Biol. Med. 1999, 26:951-960. 10.1016/S0891-5849(98)00278-0.
130. Matsumoto S., Koshiishi I., Inoguchi T., Nawata H., Utsumi H. Confirmation of superoxide generation via xanthine oxidase in streptozotocin-induced diabetic mice. Free Radic. Res. 2003, 37:767-772. 10.1080/1071576031000107344.
131. Sonta T., Inoguchi T., Tsubouchi H., Sekiguchi N., Kobayashi K., Matsumoto S., Utsumi H., Nawata H. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic. Biol. Med. 2004, 37:115-123. 10.1016/j.freeradbiomed.2004.04.001.
132. Sonta T., Inoguchi T., Matsumoto S., Yasukawa K., Inuo M., Tsubouchi H., Sonoda N., Kobayashi K., Utsumi H., Nawata H. In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochem. Biophys. Res. Commun. 2005, 330:415-422. 10.1016/j.bbrc.2005.02.174.
133. Tsubouchi H., Inoguchi T., Sonta T., Sato N., Sekiguchi N., Kobayashi K., Sumimoto H., Utsumi H., Nawata H. Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement. Free. Radic. Biol. Med. 2005, 39:444-452. 10.1016/j.freeradbiomed.2005.03.031.
134. 2+/calmodulin blockade on redox status hepatic ischemia-reperfusion injury in mice evaluated by a newly developed in vivo EPR imaging technique. J. Surg. Res. 2008, 147:41-49. 10.1016/j.jss.2007.06.024.
135. Hirayama A., Nagase S., Ueda A., Oteki T., Takada K., Obara M., Inoue M., Yoh K., Hirayama K., Koyama A. In vivo imaging of oxidative stress in ischemia-reperfusion renal injury using electron paramagnetic resonance. Am. J. Physiol. - Ren. Physiol. 2005, 288:F597-F603. 10.1152/ajprenal.00020.2004.
136. Phumala N., Ide T., Utsumi H. Noninvasive evaluation of in vivo free radical reactions catalyzed by iron content using in vivo ESR spectroscopy. Free Radic. Biol. Med. 1999, 26:1209-1217. 10.1016/S0891-5849(98)00314-1.
137. Hirayama A., Ueda A., Oteki T., Nagase S., Aoyagi K., Koyama A. In vivo imaging of renal redox status during azelnidipine treatment. Hypertens. Res. 2008, 31:1643-1650. 10.1291/hypres.31.1643.
138. Hirayama A., Yoh K., Nagase S., Ueda A., Itoh K., Morito N., Hirayama K., Takahashi S., Yamamoto M., Koyama A. EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice. Free Radic. Biol. Med. 2003, 34:1236-1242. 10.1016/S0891-5849(03)00073-X.
139. Togashi H., Oikawa K., Adachi T., Sugahara K., Ito J., Takeda T., Watanabe H., Saito K., Saito T., Fukui T., Takeda H., Ohya H., Kawata S. Mucosal sulfhydryl compounds evaluation by in vivo electron spin resonance spectroscopy in mice with experimental colitis. Gut 2003, 52:1291-1296. 10.1136/gut.52.9.1291.
140. Miura Y., Anzai K., Urano S., Ozawa T. In vivo electron paramagnetic resonance studies on oxidative stress caused by X-irradiation in whole mice. Free Radic. Biol. Med. 1997, 23:533-540. 10.1016/S0891-5849(97)00103-2.
141. Kuppusamy P., Afeworki M., Shankar R.A., Coffin D., Krishna M.C., Hahn S.M., Mitchell J.B., Zweier J.L. In vivo electron paramagnetic resonance imaging of tumor heterogeneity and oxygenation in a murine model. Cancer Res. 1998, 58:1562-1568.
142. Kuppusamy P., Li H., Ilangovan G., Cardounel A.J., Zweier J.L., Yamada K., Krishna M.C., Mitchell J.B. Noninvasive imaging of tumor redox status and its modification by tissue glutathione level. Cancer Res. 2002, 62:307-312.
143. Ilangovan G., Li H., Zweier J.L., Krishna M.C., Mitchell J.B., Kuppusamy P. In vivo measurement of regional oxygenation and imaging of redox status in RIF-1 murine tumor: effect of carbogen-breathing. Magn. Reson. Med. 2002, 48:723-730. 10.1002/mrm.10254.
144. Takeshita K., Kawaguchi K., Fujii-Akawa K., Ueno M., Okazaki S., Ono M., Krishna M.C., Kupussamy P., Ozawa T., Ikota N. Heterogeneity of regional redox status and relation of the redox status to oxygenation in a tumor model, evaluated using electron paramagnetic resonance imaging. Cancer Res. 2010, 70:4133-4140. 10.1158/0008-5472.CAN-09-4369.
145. Zhelev Z., Gadjeva V., Aoki I., Bakalova R., Saga T. Cell-penetrating nitroxides as molecular sensors for imaging of cancer in vivo, based on tissue redox activity. Mol. Biosyst. 2012, 8:2733-2740. 10.1039/c2mb25128k.
146. Bakalova R., Zhelev Z., Aoki I., Saga T. Tissue redox activity as a hallmark of carcinogenesis: from early to terminal stages of cancer. Clin. Cancer Res. 2013, 19:2503-2517. 10.1158/1078-0432.CCR-12-3726.
147. Hyodo F., Ito S., Yasukawa K., Kobayashi R., Utsumi H. Simultaneous and spectroscopic redox molecular imaging of multiple free radical intermediates using dynamic nuclear polarization-magnetic resonance imaging. Anal. Chem. 2014, 86:7234-7238. 10.1021/ac502150x.
148. Kinoshita Y., Yamada K.-I., Yamasaki T., Sadasue H., Sakai K., Utsumi H. Development of novel nitroxyl radicals for controlling reactivity with ascorbic acid. Free Radic. Res. 2009, 43:565-571. 10.1080/10715760902914575.
149. Bobko A.A., Efimova O.V., Voinov M.A., Khramtsov V.V. Unique oxidation of imidazolidine nitroxides by potassium ferricyanide: strategy for designing paramagnetic probes with enhanced sensitivity to oxidative stress. Free Radic. Res. 2012, 46:1115-1122. 10.3109/10715762.2012.692785.
150. Paletta J.T., Pink M., Foley B., Rajca S., Rajca A. Synthesis and reduction kinetics of sterically shielded pyrrolidine nitroxides. Org. Lett. 2012, 14:5322-5325. 10.1021/ol302506f.
151. Jagtap A.P., Krstic I., Kunjir N.C., Hänsel R., Prisner T.F., Sigurdsson S.T. Sterically shielded spin labels for in-cell EPR spectroscopy: analysis of stability in reducing environment. Free Radic. Res. 2015, 49:78-85. 10.3109/10715762.2014.979409.
152. Liu Y., Song Y., De Pascali F., Liu X., Villamena F.A., Zweier J.L. Tetrathiatriarylmethyl radical with a single aromatic hydrogen as a highly sensitive and specific superoxide probe. Free Radic. Biol. Med. 2012, 53:2081-2091. 10.1016/j.freeradbiomed.2012.09.011.
153. Redler G., Barth E.D., Bauer K.S., Kao J.P.Y., Rosen G.M., Halpern H.J. In vivo electron paramagnetic resonance imaging of differential tumor targeting using cis-3,4-di(acetoxymethoxycarbonyl)-2,2,5,5-tetramethyl-1-pyrrolidinyloxyl. Magn. Reson. Med. 2014, 71:1650-1656. 10.1002/mrm.24813.